# Bumble Inc.: financial statements, quarterly

BMBL · Nasdaq · CIK 1830043 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bmbl.md) · [Financials](/companies/bmbl/financials.md) · [Filings](/companies/bmbl/filings.md) · [Insiders](/companies/bmbl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bmbl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [276](/filings/0000950170-24-124066.md) | [274 d](/filings/0001830043-26-000027.md) | [268](/filings/0000950170-25-069174.md) | [269](/filings/0001628280-25-038861.md) | [274](/filings/0001830043-25-000046.md) | [262 d](/filings/0001830043-26-000027.md) | [247](/filings/0001830043-26-000060.md) | [248](/filings/0001830043-26-000104.md) | [246](/filings/0001830043-25-000046.md) | [224 d](/filings/0001830043-26-000027.md) | [212](/filings/0001830043-26-000060.md) | [211](/filings/0001830043-26-000104.md) |
| Cost of revenue | $m | [14.0](/filings/0000950170-23-061214.md) | [0.8 d](/filings/0000950170-24-022104.md) | [2.5](/filings/0000950170-24-057159.md) | [0.0](/filings/0000950170-24-093910.md) | [0.0](/filings/0000950170-24-124066.md) | [0.0 d](/filings/0000950170-25-030151.md) | [73.4](/filings/0001830043-26-000060.md) | [74.3](/filings/0001830043-26-000104.md) | [69.2](/filings/0001830043-25-000046.md) | [64.6 d](/filings/0001830043-26-000027.md) | [54.8](/filings/0001830043-26-000060.md) | [54.0](/filings/0001830043-26-000104.md) |
| Operating income | $m | [30.0](/filings/0000950170-24-124066.md) | [(6.9) d](/filings/0001830043-26-000027.md) | [48.8](/filings/0000950170-25-069174.md) | [52.0](/filings/0001628280-25-038861.md) | [(838)](/filings/0001830043-25-000046.md) | [37.0 d](/filings/0001830043-26-000027.md) | [44.7](/filings/0001830043-26-000060.md) | [(338)](/filings/0001830043-26-000104.md) | [63.7](/filings/0001830043-25-000046.md) | [(576) d](/filings/0001830043-26-000027.md) | [65.3](/filings/0001830043-26-000060.md) | [(112)](/filings/0001830043-26-000104.md) |
| Income tax | $m | [1.9](/filings/0000950170-24-124066.md) | [(0.1) d](/filings/0001830043-26-000027.md) | [7.5](/filings/0000950170-25-069174.md) | [4.6](/filings/0001628280-25-038861.md) | [4.2](/filings/0001830043-25-000046.md) | [6.9 d](/filings/0001830043-26-000027.md) | [6.0](/filings/0001830043-26-000060.md) | [6.5](/filings/0001830043-26-000104.md) | [9.5](/filings/0001830043-25-000046.md) | [12.4 d](/filings/0001830043-26-000027.md) | [11.4](/filings/0001830043-26-000060.md) | [(2.4)](/filings/0001830043-26-000104.md) |
| Net income | $m | [16.7](/filings/0000950170-24-124066.md) | [(26.0) d](/filings/0001830043-26-000027.md) | [24.6](/filings/0000950170-25-069174.md) | [27.4](/filings/0001628280-25-038861.md) | [(613)](/filings/0001830043-25-000046.md) | [4.2 d](/filings/0001830043-26-000027.md) | [13.4](/filings/0001830043-26-000060.md) | [(254)](/filings/0001830043-26-000104.md) | [37.3](/filings/0001830043-25-000046.md) | [(490) d](/filings/0001830043-26-000027.md) | [45.2](/filings/0001830043-26-000060.md) | [(110)](/filings/0001830043-26-000104.md) |
| Diluted EPS | $ per share | [0.12](/filings/0000950170-24-124066.md) | not reported | [0.19](/filings/0000950170-25-069174.md) | [0.22](/filings/0001628280-25-038861.md) | [(5.11)](/filings/0001830043-25-000046.md) | not reported | [0.13](/filings/0001830043-26-000060.md) | [(2.45)](/filings/0001830043-26-000104.md) | [0.33](/filings/0001830043-25-000046.md) | not reported | [0.34](/filings/0001830043-26-000060.md) | [(0.84)](/filings/0001830043-26-000104.md) |
| Basic EPS | $ per share | [0.12](/filings/0000950170-24-124066.md) | not reported | [0.19](/filings/0000950170-25-069174.md) | [0.22](/filings/0001628280-25-038861.md) | [(5.11)](/filings/0001830043-25-000046.md) | not reported | [0.13](/filings/0001830043-26-000060.md) | [(2.45)](/filings/0001830043-26-000104.md) | [0.34](/filings/0001830043-25-000046.md) | not reported | [0.35](/filings/0001830043-26-000060.md) | [(0.84)](/filings/0001830043-26-000104.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [439](/filings/0000950170-24-124066.md) | [356](/filings/0001830043-26-000027.md) | [263](/filings/0000950170-25-069174.md) | [287](/filings/0001628280-25-038861.md) | [252](/filings/0001830043-25-000046.md) | [204](/filings/0001830043-26-000027.md) | [202](/filings/0001830043-26-000060.md) | [262](/filings/0001830043-26-000104.md) | [308](/filings/0001830043-25-000046.md) | [176](/filings/0001830043-26-000104.md) | [246](/filings/0001830043-26-000060.md) | [154](/filings/0001830043-26-000104.md) |
| Current assets | $m | [584](/filings/0000950170-23-061214.md) | [493](/filings/0000950170-25-030151.md) | [394](/filings/0000950170-24-057159.md) | [420](/filings/0000950170-24-093910.md) | [383](/filings/0000950170-24-124066.md) | [342](/filings/0001830043-26-000027.md) | [338](/filings/0000950170-25-069174.md) | [398](/filings/0001628280-25-038861.md) | [437](/filings/0001830043-25-000046.md) | [305](/filings/0001830043-26-000104.md) | [357](/filings/0001830043-26-000060.md) | [277](/filings/0001830043-26-000104.md) |
| Total assets | $m | [3,733](/filings/0000950170-23-061214.md) | [3,625](/filings/0000950170-25-030151.md) | [3,517](/filings/0000950170-24-057159.md) | [3,524](/filings/0000950170-24-093910.md) | [2,589](/filings/0000950170-24-124066.md) | [2,525](/filings/0001830043-26-000027.md) | [2,508](/filings/0000950170-25-069174.md) | [2,161](/filings/0001628280-25-038861.md) | [2,193](/filings/0001830043-25-000046.md) | [1,425](/filings/0001830043-26-000104.md) | [1,473](/filings/0001830043-26-000060.md) | [1,220](/filings/0001830043-26-000104.md) |
| Current liabilities | $m | [197](/filings/0000950170-23-061214.md) | [245](/filings/0000950170-25-030151.md) | [201](/filings/0000950170-24-057159.md) | [176](/filings/0000950170-24-093910.md) | [183](/filings/0000950170-24-124066.md) | [139](/filings/0001830043-26-000027.md) | [119](/filings/0000950170-25-069174.md) | [120](/filings/0001628280-25-038861.md) | [123](/filings/0001830043-25-000046.md) | [138](/filings/0001830043-26-000104.md) | [293](/filings/0001830043-26-000060.md) | [171](/filings/0001830043-26-000104.md) |
| Total liabilities | $m | [1,253](/filings/0000950170-23-061214.md) | [1,288](/filings/0000950170-25-030151.md) | [1,254](/filings/0000950170-24-057159.md) | [1,226](/filings/0000950170-24-093910.md) | [1,223](/filings/0000950170-24-124066.md) | [1,176](/filings/0001830043-26-000027.md) | [1,154](/filings/0000950170-25-069174.md) | [1,157](/filings/0001628280-25-038861.md) | [1,156](/filings/0001830043-25-000046.md) | [744](/filings/0001830043-26-000104.md) | [738](/filings/0001830043-26-000060.md) | [604](/filings/0001830043-26-000104.md) |
| Long-term debt | $m | [616](/filings/0000950170-23-061214.md) | [615](/filings/0000950170-25-030151.md) | [614](/filings/0000950170-24-057159.md) | [613](/filings/0000950170-24-093910.md) | [612](/filings/0000950170-24-124066.md) | [611](/filings/0001830043-26-000027.md) | [610](/filings/0000950170-25-069174.md) | [609](/filings/0001628280-25-038861.md) | [584](/filings/0001830043-25-000046.md) | [583](/filings/0001830043-26-000104.md) | [429](/filings/0001830043-26-000060.md) | [399](/filings/0001830043-26-000104.md) |
| Current portion of debt | $m | [5.8](/filings/0000950170-23-061214.md) | [5.8](/filings/0000950170-25-030151.md) | [5.8](/filings/0000950170-24-057159.md) | [5.8](/filings/0000950170-24-093910.md) | [5.8](/filings/0000950170-24-124066.md) | [5.8](/filings/0001830043-26-000027.md) | [5.8](/filings/0000950170-25-069174.md) | [5.8](/filings/0001628280-25-038861.md) | [5.8](/filings/0001830043-25-000046.md) | [5.8](/filings/0001830043-26-000104.md) | [159](/filings/0001830043-26-000060.md) | [52.2](/filings/0001830043-26-000104.md) |
| Shareholders' equity | $m | [1,690](/filings/0000950170-23-061214.md) | [1,635](/filings/0000950170-25-030151.md) | [1,604](/filings/0000950170-24-057159.md) | [1,653](/filings/0000950170-24-093910.md) | [853](/filings/0000950170-24-124066.md) | [825](/filings/0001830043-26-000027.md) | [815](/filings/0000950170-25-069174.md) | [578](/filings/0001628280-25-038861.md) | [675](/filings/0001830043-25-000046.md) | [570](/filings/0001830043-26-000104.md) | [617](/filings/0001830043-26-000060.md) | [516](/filings/0001830043-26-000104.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.6 d](/filings/0000950170-24-124066.md) | [63.4 d](/filings/0001830043-26-000027.md) | [2.4](/filings/0000950170-25-069174.md) | [32.9 d](/filings/0001628280-25-038861.md) | [93.5 d](/filings/0001830043-25-000046.md) | [(5.4) d](/filings/0001830043-26-000027.md) | [43.2](/filings/0001830043-26-000060.md) | [71.2 d](/filings/0001830043-26-000104.md) | [76.8 d](/filings/0001830043-25-000046.md) | [59.1 d](/filings/0001830043-26-000027.md) | [77.2](/filings/0001830043-26-000060.md) | [53.6 d](/filings/0001830043-26-000104.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-124066.md) | [91.9 d](/filings/0001830043-26-000027.md) | [62.1](/filings/0000950170-25-069174.md) | [0.0 d](/filings/0001628280-25-038861.md) | [89.7 d](/filings/0001830043-25-000046.md) | [40.3 d](/filings/0001830043-26-000027.md) | [28.7](/filings/0001830043-26-000060.md) | [0.0 d](/filings/0001830043-26-000104.md) | [0.0 d](/filings/0001830043-25-000046.md) | [0.0 d](/filings/0001830043-26-000027.md) | [0.0](/filings/0001830043-26-000060.md) | [0.0 d](/filings/0001830043-26-000104.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q3 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [194](/filings/0000950170-23-061214.md) | [132](/filings/0000950170-24-057159.md) | [191](/filings/0000950170-24-093910.md) | [191](/filings/0000950170-24-124066.md) | [129](/filings/0000950170-25-069174.md) | [126](/filings/0001628280-25-038861.md) | [120](/filings/0001830043-25-000046.md) | [105](/filings/0001830043-26-000060.md) | [103](/filings/0001830043-26-000104.md) | [155](/filings/0001830043-25-000046.md) | [130](/filings/0001830043-26-000060.md) | [131](/filings/0001830043-26-000104.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 119,799,036 at 2021-07-31, from the cover of the [10-Q filed 2021-08-13](/filings/0000950170-21-001439.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.